FR1959M - Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration. - Google Patents

Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration.

Info

Publication number
FR1959M
FR1959M FR904104A FR904104A FR1959M FR 1959 M FR1959 M FR 1959M FR 904104 A FR904104 A FR 904104A FR 904104 A FR904104 A FR 904104A FR 1959 M FR1959 M FR 1959M
Authority
FR
France
Prior art keywords
lipotropic
eutrophic
pyridoxine
pantothenate
cutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR904104A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH S PHARMACOTECHNIQUES SOC
Original Assignee
RECH S PHARMACOTECHNIQUES SOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH S PHARMACOTECHNIQUES SOC filed Critical RECH S PHARMACOTECHNIQUES SOC
Priority to FR904104A priority Critical patent/FR1959M/fr
Application granted granted Critical
Publication of FR1959M publication Critical patent/FR1959M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR904104A 1962-07-16 1962-07-16 Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration. Expired FR1959M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR904104A FR1959M (fr) 1962-07-16 1962-07-16 Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR904104A FR1959M (fr) 1962-07-16 1962-07-16 Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration.

Publications (1)

Publication Number Publication Date
FR1959M true FR1959M (fr) 1963-08-05

Family

ID=87557041

Family Applications (1)

Application Number Title Priority Date Filing Date
FR904104A Expired FR1959M (fr) 1962-07-16 1962-07-16 Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration.

Country Status (1)

Country Link
FR (1) FR1959M (fr)

Similar Documents

Publication Publication Date Title
FR3384M (fr) Nouvelle composition pour aérosols pharmaceutiques.
BE772190A (fr) Nouvelles compositions pharmaceutiques
CH551197A (fr) Emulsion, procede pour sa preparation et son utilisation dans des compositions cosmetiques.
BE782981A (fr) Compositions pharmaceutiques
FR3152M (fr) N-alkyl- et n-arylalkyl-benzoxacyclo-alkane-carboxamides comme analgésiques et hypotenseurs.
BE782444A (fr) Compositions pharmaceutiques
BE774033A (fr) Compositions pharmaceutiques anti-allergiques
BE776789A (fr) Compositions pharmaceutiques anesthesiques destinees a l'injection intraveineuse
FR2046M (fr) Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration.
FR2664M (fr) Nouvelles préparations pharmaceutiques a action prolongée.
BE744083A (fr) Nouvelles preparations pharmaceutiques
FR2116M (fr) Compositions thérapeutiques a action prolongée pour l'administration orale de l'oxy-tétracycline.
FR1782M (fr) Le nicotinate de cétyle comme antalgique et révulsif et les compositions pharmaceutiques pour son administration, notamment par voie percutanée.
FR2285871A1 (fr) Compositions pharmaceutiques
FR1940M (fr) Le nicotinate de pyridoxine comme lipotrope, vasodilatateur et eutrophique cutané et les compositions pharmaceutiques pour son administration.
BE791253A (fr) Nouvelles preparations pharmaceutiques pour le traitement de l'hypertonie
FR2849M (fr) Composition pour soins dentaires.
BE784835A (fr) Nouvelles preparations pharmaceutiques
FR2501M (fr) Le succinate de di-p.acétaminophénol comme antirhumatismal analgésique antipyrétique et les compositions pharmaceutiques pour son administration.
FR3392M (fr) Médicament dermatologique, notamment pour le traitement de l'eczéma suintant.
FR2128M (fr) L'aspartate d'heptaminol comme antiasthénique et défatigant et les compositions pharmaceutiques pour son administration.
FR2250M (fr) Composition thérapeutique pour administration orale.
BE757085A (fr) Nouvelles compositions pharmaceutiques
BE763000A (fr) Nouvelles preparations pharmaceutiques
FR2081518A1 (fr) Nouvelles preparations pharmaceutiques